Institutional investors purchased a net $3.6 million shares of OPK during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 18.11% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INTEGRAL DERIVATIVES LLC Bought 315.9 Thousand shares of OPKO Health Inc
CAPITAL FUND MANAGEMENT SA Bought 142.3 Thousand shares of OPKO Health Inc
MIZUHO SECURITIES USA, INC. Bought 115.5 Thousand shares of OPKO Health Inc